company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7495000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7495000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,173000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1740000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,780000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4660000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4660000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-56936000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-5000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57038000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57038000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2028000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,61024000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9984000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68980000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68980000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7282000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,615000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13697000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13697000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,166000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,459000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1135000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8977000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2960000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2960000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-214000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26141000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17202000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9153000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9153000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7101000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1455000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1455000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10658000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1917000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,160000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-269000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1983000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,573000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12848000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12848000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-137000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12057000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24885000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12691000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12691000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,67000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,67000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-90000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,194000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4403000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4403000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,163000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1216000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,647000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7573000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7573000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6018000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19820000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13677000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13677000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,284000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-84000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6304000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,235000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14549000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14549000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,163000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1064000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2611000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,524000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12315000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12315000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14547000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16835000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2213000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2213000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-284000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,293000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7972000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7972000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2130000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,255000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14327000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14327000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,127000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1245000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,189000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12598000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12598000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30810000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21428000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9484000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9484000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20153000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20153000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20153000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1929000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,364000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14840000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14840000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,433000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,831000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2466000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15871000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15871000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-120000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8547000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17107000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8440000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8440000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-872000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20166000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-20153000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-859000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-859000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8290000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,425000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,984000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1966000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15055000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15055000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13895000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13815000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13815000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1359000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,225000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10866000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10866000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9626000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,414000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12476000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12476000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,271000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1076000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-441000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11413000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11413000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-138000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25717000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12500000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13355000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13355000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2080000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22607000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20527000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20527000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4241000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,552000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15078000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15078000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,139000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,265000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,949000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1669000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12056000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12056000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5017000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19270000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14228000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14228000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2491000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1531000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-960000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-960000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1212000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14096000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14096000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,134000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,72000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2773000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-863000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11980000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11980000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10067000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22921000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22921000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24102000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,30000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26421000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1650000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30669000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30669000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4232000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2427000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,127000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,525000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1074000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2587000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12496000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12496000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5503000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15978000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10426000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10426000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,830000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,830000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,830000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1240000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,835000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,130748000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,130748000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,107000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,281000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1636000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5959000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,126813000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,126813000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-349000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9306000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19190000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19190000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,877000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1483000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1303000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1057000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1057000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,108680000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,883000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,108000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,552000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4736000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4540000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20316000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20316000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-162000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98599000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18442000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80319000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80319000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,672000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,672000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,672000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-99963000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,874000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1800000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24508000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24508000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,120000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,528000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3191000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4653000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16016000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16016000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10753000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31880000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20931000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20931000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,255000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,255000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,255000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5170000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,893000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1800000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31342000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31342000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,129000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,515000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3742000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,39539000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12583000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12583000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-253000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-51372000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29575000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22050000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22050000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6413000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6363000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6363000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3104000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,893000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10124000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10124000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,142000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1177000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5576000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12346000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15575000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15575000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-72000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-82759000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38621000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44210000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44210000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29950000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,90500000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4076000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58918000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58918000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-867000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1037000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1291000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3981000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13220000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5678000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5678000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48402000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46309000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2188000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2188000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2579000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2579000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2579000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6069000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 16:37:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,151000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1302000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4152000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16155000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23746000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23746000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-292000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27194000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34903000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7417000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7417000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1759000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1759000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1759000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14570000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,900000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16177000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16177000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,158000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1241000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5229000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14670000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24219000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24219000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-159000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37328000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,63257000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25770000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25770000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1168000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1168000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1168000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2719000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18914000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18914000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,173000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1117000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5099000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1460000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13985000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13985000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-265000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54773000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107054000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,52016000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,52016000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5437000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5437000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5437000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43468000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,901000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1007000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5332000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9588000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9588000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-70000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54795000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32790000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22075000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22075000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2958000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2958000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2958000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28705000.0
